Development and structure-activity relationship of tacrine derivatives as highly potent CDK2/9 inhibitors for the treatment of cancer
- Resource Type
- Article
- Source
- In
European Journal of Medicinal Chemistry 15 November 2022 242 - Subject
- Language
- ISSN
- 0223-5234